Insights from SABCS 2024 part 2
The SABCS 2024 (San Antonio Breast Cancer Symposium) is taking place from December 10th to 13th, 2024 at the Henry B. Gonzalez Convention Center in San Antonio, TX, USA.
SABCS is expected to attract around 10,000+ attendees from more than 102 countries, including oncologists, researchers, and healthcare professionals.
This Symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancerand premalignant breast disease to an international audience of academic and private physicians and researchers.
New work on a cell atlas of normal breast tissue
“New work on a cell atlas of normal breast tissue may facilitate the early prediction and even prevention of breast cancer. This new resource will be the focus of the second Plenary Lecture Friday morning at SABCS24.
Learn more in SABCS Meeting News.”
“Lajos Pusztai, Christina Minami, and Hans Wildiers discussed ‘Breast Cancer in Older Adults’ in an SABCS24 Educational Session moderated by Mina Sedrak.”
Distinguished Lecture in Breast Cancer Research by Steffi Oesterreich
“Steffi Oesterreich, coleader of the Cancer Biology Program at UPMC Hillman Cancer Center, delivered the Distinguished Lecture in Breast Cancer Research this afternoon at SABCS24.”
Revolutionizing Diagnosis and Discovery
“Revolutionizing Diagnosis and Discovery with Artificial Intelligence: Kun-Hsing Yu, Ritse Mann, and Erika Hamilton addressed this topic in a State of the Art session moderated by Fred Howard.”
“Nobel Prize winner William G. Kaelin, Jr., MD, presented the SABCS24 keynote address and spoke about building novel, effective drug combinations. Learn more in SABCS Meeting News.”
“Fergus Couch, Antonis Antoniou, Katherine Nathanson, and Tanja Spanic discussed ‘The Future of Cancer Genetics’ in a special SABCS24 session moderated by Claudine Isaacs.”
Laura J. van ‘t Veer delivered the William L. McGuire Memorial Lecture yesterday at SABCS24
“Laura J. van ‘t Veer delivered the William L. McGuire Memorial Lecture yesterday at SABCS24. Dr. van ‘t Veer was recognized for her work in advancing risk stratification, subtyping, and improved treatment.”
Unraveling Social vs Biological Drivers of Racial Disparities in Cancer Outcomes
“The Grand Challenge of Unraveling Social vs Biological Drivers of Racial Disparities in Cancer Outcomes: Melissa B. Davis addressed this topic in a plenary lecture at SABCS24.”
“Patients with low-risk DCIS had similar quality of life whether they underwent active monitoring or received upfront treatment, according to results presented by Ann Partridge, MD, MPH, at SABCS24.”
“Late Breaking: In PATINA trial, patients with HR-positive, HER2-positive metastatic breast cancer had improved progression-free survival when palbociclib was added to endocrine and anti-HER2 therapy, says Otto Metzger, MD at SABCS24.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023